AstraZeneca, GSK and Teva among manufacturers accused of “improper” submission of patents | More than 300 patents targeted in ...

Ahead of her panel discussion at LSPN North America, Kady Bruce shares insights into her role and how she ensures BioNTech’s ...

Amgen has settled its patent infringement litigation with Sandoz, it was announced yesterday (April 29), with a deal that ...

CureVac and Acuitas Therapeutics have settled their COVID-19 vaccine dispute. According to a filing, submitted April 25, 2024 ...

Former senior legal advisor at USPTO brings wealth of life sciences experience | Move represents transition back into private practice after two decades. After almost 20 years at the US Patent and ...

One of the pivotal challenges in the development and commercialisation of cell and gene therapies (CGT) lies in scaling up ...

UK High Court invalidates two patents due to “overwhelming evidence” supplied by defendant | Biotech firm files same claims ...

Dutch biotech ProQR has successfully defended a patent covering its ribonucleic acid (RNA) editing platform Axiomer, ...

Vanda denied opportunity to revive patents for its sleep-disorder drug in dispute against Teva | Decision also rejects ...

GSK subsidiary ViiV Healthcare and Exavir Therapeutics have settled their dispute over licensing rights for HIV drug ...

New claim from GlaxoSmithKline is latest in litany of lawsuits against rivals | US lawsuit, potentially worth “billions of ...